Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 85%
filed 2026-07-06
Item 8.01
The filing discloses the appointment of two named executives: Scott David Miller as Product & Analytics Lead (effective July 2, 2026) and Thomas Bennett as Data Science / Modeling Lead (effective July 3, 2026). Both appointments are presented as part of management's strategic expansion of technical capabilities and are material to the company's operational and product development strategy. While the Item 8.01 caption is "Other Events," the substance is clearly executive appointment(s) that strengthen core technical infrastructure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-06
Item 1.01
The Board approved an amendment to accelerate the expiration of the Company's stockholder rights plan (poison pill) from February 2, 2027 to July 6, 2026, effective immediately. The Board determined that maintaining the rights plan is no longer necessary to serve the best interests of all stockholders, eliminating the Company's anti-takeover defenses.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 8.01
Edgemode entered into a non-binding term sheet on July 1, 2026 regarding the sale of its interest in land sites in Spain to a third-party purchaser for data center development. Although the term sheet is non-binding and subject to due diligence and definitive documentation, the disclosure of a material disposition of real property assets—structured as a share purchase of entities holding the land—constitutes a material M&A activity event. The company also retained a joint venture option, indicating a significant strategic transaction. The materiality is evident from the detailed disclosure of the transaction structure, exclusivity period, and conditions precedent.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-06
Item 2.03
On June 30, 2026, the Company entered into an Exchange Agreement issuing a Promissory Note (Exchange Note) with a principal amount of $1,299,870 bearing 9.5% interest and maturing July 30, 2027, in exchange for cancellation of Series 2 Convertible Preferred Stock. The Exchange Note constitutes a new direct financial obligation with monthly redemption rights and trigger events including delisting and covenant breaches.
View raw filing on EDGAR →
8-K
Governance Other
confidence 70%
filed 2026-07-06
Item 5.03
The Company amended the Certificate of Designations for Series 2 Convertible Preferred Stock, materially modifying security holder rights and preferred share terms including conversion price, anti-dilution provisions, elimination of liquidation event triggers, and removal of forced redemption rights.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-06
Item 5.02
The filing discloses the appointment of Lynn Seely, M.D. as a new Class III director to AbCellera's Board of Directors effective June 30, 2026. The principal disclosed action is a person taking a governance role. Dr. Seely is an independent director with substantial biopharmaceutical executive experience, including CEO roles at Lyell Immunopharma and Myovant Sciences, and prior board service at Blueprint Medicines (acquired for $9.1 billion). This is a material governance event affecting the composition and expertise of the board.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 7.01
Splash Beverage Group entered into an exclusive global licensing agreement with Argent BioPharma Limited to acquire worldwide rights to CannEpil®, a cannabinoid-based epilepsy therapeutic. The transaction includes $5.5 million in newly issued preferred equity consideration, a $1 million strategic investment commitment, and represents a material acquisition of intellectual property and commercial rights that aligns with the company's stated strategic transformation toward a cannabinoid biopharmaceutical platform. This constitutes a material acquisition activity under Item 1.01/2.01 framework.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-06
EX-99.1
CDT Environmental Technology Investment Holdings Ltd called an Extraordinary General Meeting for July 28, 2026, to seek shareholder approval for five material governance and capital structure resolutions: a company name change to 宸邦科技, a 125-fold increase in authorized share capital (from US$250,000 to US$31,250,000), a share consolidation at a 1-for-5 to 1-for-10 ratio, a redesignation of 182,983 Class A shares to Class B shares with enhanced voting rights for the founder, and omnibus director authorizations. These changes would materially affect the company's share structure, voting rights, and investor holdings.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-06
Item 5.02
The filing discloses the appointment of Aleksandr Zhandov as Chief Operating Officer and Deputy Chief Executive Officer effective July 6, 2026. While the disclosure includes employment agreement terms (base salary of $120,000, at-will employment, discretionary bonuses and equity), the principal disclosed action is the appointment of a named executive to a senior officer role reporting to the CEO. This is a material governance event affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 1.01
The Company entered into an Exclusive License Agreement acquiring worldwide rights to CannEpil®, a pharmaceutical product for treatment of epilepsy and seizure disorders, with a 20-year initial term, defined development milestones, and royalty obligations of 15% of net revenue. The transaction includes issuance of $5.5 million in Series D Preferred Stock as consideration, establishing a significant new business line and financial obligation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-06
Item 3.02
The Company issued 5,500 shares of unregistered Series D Convertible Preferred Stock (stated value $1,000 per share, convertible at $0.25 per share subject to a $0.15 floor) to an accredited investor under Section 4(a)(2) and Rule 506(b) as consideration for the CannEpil® license acquisition, with C/M Capital Partners committing to invest at least $1 million within 60 days and a contingent $1 million sales bonus upon achieving $5 million in cumulative net revenue.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-06
EX-99.1
Bitzero announced a land reservation agreement for approximately 33 hectares in Finland supporting up to 60MW of capacity, representing a strategic expansion of its Nordic development portfolio for HPC and data center infrastructure. This is a material operational milestone reflecting the company's long-term infrastructure strategy, though it is not a binding acquisition or lease (terms to be finalized) and thus does not qualify as ma_activity. The disclosure also includes a routine investor relations engagement with Think Ink for a two-week marketing campaign.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 1.01
ClearOne entered into a definitive Agreement and Plan of Merger on July 1, 2026, whereby its wholly-owned subsidiary will merge with Cortigent, Inc. (a subsidiary of Vivani Medical), with Cortigent surviving as a wholly-owned subsidiary of ClearOne. The transaction involves the issuance of 12.5 million consideration shares, concurrent $10–15 million financing, board and management reconstitution, and a company rename to 'Cortigent Holdings, Inc.,' with Vivani owning 59.4% to 67.5% of the combined company post-closing and expected to close in Q3 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 7.01
Clarivate announced a definitive agreement to divest its Life Sciences & Healthcare segment to Altaris LLC for $600 million in cash and a seller note. This is a material disposition of a business segment representing a significant portion of the company's operations. The transaction includes customary representations, warranties, and covenants, and is expected to close by year-end 2026, with proceeds earmarked for debt reduction and strategic portfolio rationalization.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-06
Item 8.01
Mr. John Prince's death results in his departure from the Claritev Board of Directors, where he served since June 2023 and held a position on the Audit Committee. While disclosed under Item 8.01 (Other Information) rather than the typical Item 5.02, the substance is a director departure due to death, which is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-06
The filing discloses Item 5.07 results of a shareholder vote at the Fund's reconvened Annual Meeting held on June 29, 2026, reporting the election of three Trustees (Frank J. Fahrenkopf, Jr., Colin J. Kilrain, and Salvatore J. Zizza) with specific vote tallies. This is a classic shareholder_vote_results disclosure documenting the outcome of a contested trustee election where each nominee received affirmative votes from a majority of outstanding shares.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-06
Item 5.03
UbuyHoldings, Inc. implemented a 1-for-10 reverse stock split and changed its corporate name to Longevity Diversified Holdings, Inc., with a corresponding ticker symbol change from UBHY to LGVT. Both actions were shareholder-approved amendments to the Articles of Incorporation and materially affect the company's capital structure and corporate identity.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-06
EX-99.1
Veraxa Biotech AG has scheduled an extraordinary general meeting for 24 July 2026 to seek shareholder approval for three governance and capital structure matters: (1) increase in conditional capital for shareholder options and amendment of Article 3a; (2) increase in capital band and amendment of Article 3d; and (3) increase in the number of Board members from up to seven and amendment of Article 15. These changes would materially affect the company's capitalization structure and board composition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-06
EX-99.2
Veraxa Biotech AG announced the initiation of cell line development with ATUM for its lead BiTAC-TCE program, described as a key milestone in translating the therapeutic candidate into a manufacturable product and advancing toward IND/CTA-enabling activities.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-06
EX-99.3
Veraxa Biotech AG disclosed a material strategic and pipeline update, including decisions to focus investment on BiTAC-based programs, monetize non-BiTAC assets, and pursue partnering initiatives, with VXA-102 targeted to be IND/CTA-ready by early 2028.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-07-06
Item 4.01
CXApp Inc. dismissed WithumSmith+Brown, PC as its independent registered public accounting firm on June 30, 2026, and appointed KNAV CPA LLP as the new auditor for fiscal year 2026. The prior auditor had identified material weaknesses in internal control over financial reporting (income tax accruals, period-end expense accruals, and embedded derivatives accounting) that were remediated by December 31, 2025.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-06
Item 5.02
Melissa G. Podruzny was appointed as Interim CFO effective July 1, 2026, following the departure of CFO Joy L. Mbanugo on June 29, 2026. Ms. Podruzny's compensation includes a CAD $141,180 base salary, CAD $30,000 interim premium, CAD $20,000 transition bonus, and a 50,000-share stock option grant with a 24-month vesting schedule.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-07-06
Item 1.01
FortuneX Acquisition Corp entered into Amendment No. 1 to its Underwriting Agreement on July 1, 2026, revising terms related to its initial public offering, including provisions on Firm Units, Option Units, deferred underwriting discount, private placement units, and trust account acknowledgements. While this is a material definitive agreement under Item 1.01, it does not fit cleanly into the M&A activity category (which typically covers acquisitions, dispositions, mergers, or changes of control of the registrant itself) nor any other specific event type; it is a capital-raising and IPO-related amendment that would materially affect investors' understanding of the offering structure and terms.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 72%
filed 2026-07-06
Item 1.01
P3 Health Partners amended an existing repurchase promissory note, extending its maturity to September 30, 2028, and modifying interest terms to accrue PIK (payment-in-kind) interest at 14% per annum. While this is technically an amendment to existing debt rather than a new issuance, it materially modifies the registrant's direct financial obligations by extending the repayment timeline and increasing the effective cost through PIK interest accrual. The 14% PIK rate and extended maturity are material modifications that would affect investor assessment of the company's debt obligations and liquidity.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-07-06
EX-99.1
Dara Khosrowshahi, CEO of Uber and a board member of Grab since 2018, has stepped down from Grab's Board of Directors effective July 6, 2026. This is a clear executive departure—the principal disclosed action is a director leaving the board. The disclosure explicitly states he "has stepped down from its Board of Directors" and notes his eight-year tenure, making this a material governance event affecting board composition and independence.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-07-06
EX-99.1
Dara Khosrowshahi, a named individual, has stepped down from Grab's Board of Directors effective July 6, 2026. This is a departure of a director and constitutes a material governance change affecting board composition and independence ratios, which would affect a reasonable investor's assessment of the company's governance structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 93%
filed 2026-07-06
Item 1.01
Diversified Energy Company, through subsidiary DP Eagle LLC, issued $895 million in aggregate principal amount of asset-backed securities (Class A-1, A-2, and B Notes) on July 2, 2026, pursuant to Section 4(a)(2) of the Securities Act. The securities are secured by upstream producing assets in the Anadarko basin with anticipated repayment in 2031 and legal maturity in 2046, with proceeds used to fund asset acquisition and transaction costs.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 2.01
Diversified Energy Company completed a material acquisition of oil and natural gas assets in Oklahoma for approximately $1.175 billion. The acquisition was funded through a 60% equity contribution from Carlyle and debt financing, closing pursuant to a Securities Purchase Agreement for developed and undeveloped assets.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 95%
filed 2026-07-06
The 6-K discloses the resignation of HHL LLP as independent auditor effective June 26, 2026, and the appointment of HCL, PLLC as the new auditor on the same date. The filing explicitly states no disagreements or reportable events occurred during the engagement, and the former auditor issued no reports. This is a material auditor change requiring disclosure under Item 4.01 of Form 8-K (and analogous 6-K disclosure requirements).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-06
Item 3.02
Blue Owl Real Estate Net Lease Trust sold 18.5 million common shares for approximately $198.3 million in gross proceeds on July 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-06
Item 8.01
The company declared distributions to shareholders across four classes of common shares (Class S, N, D, and I) with per-share amounts of $0.0625000 gross, including record dates and payment dates, net of shareholder servicing fees and with reinvestment plan options available.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-06
The filing discloses the appointment of two individuals, David Gaertner and David Mutina, to the Company's Board of Directors on July 2, 2026. Item 5.02 explicitly covers director appointments, and the prose confirms both individuals were appointed to serve as board members with their qualifications and backgrounds detailed. This is a material governance event affecting the composition of the board.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-06
Item 8.01
The filing discloses a declared cash distribution of $140,003 to shareholders of record on July 7, 2026, payable on July 8, 2026. The distribution represents proceeds from staking rewards earned by the Trust on its AVAX holdings from January 8, 2026 through June 30, 2026. This is a classic dividend/distribution disclosure under Item 8.01, and is material as it represents the Trust's first cash distribution to shareholders and affects their economic returns.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 7.01
Versant Media Group announced entry into a definitive stock purchase agreement to acquire Full Swing Golf Holdings for approximately $530 million in cash, subject to customary adjustments, with expected closing in the second half of 2026. This is a material acquisition disclosed via press release (Exhibit 99.1) under Item 7.01, representing a significant strategic transaction that would materially affect investor assessment of the registrant's capital deployment and business portfolio expansion.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-02
Item 1.01
Avnet amended its Receivables Purchase Agreement to increase the maximum purchase limit from $500 million to $700 million and extended the termination date to July 1, 2028, materially increasing the Company's available liquidity and borrowing capacity by $200 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-02
Item 8.01
Ford's news release dated July 2, 2026 discloses second-quarter and first-half 2026 U.S. sales results, including total sales of 1,006,515 vehicles for the first half, market share data (12.3% June retail share), and detailed performance metrics across product lines (F-Series, Bronco, Explorer, Expedition, Maverick, etc.). This is a quarterly sales and operational performance disclosure typical of earnings releases, filed as Exhibit 99 and incorporated by reference under Item 8.01.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-02
Item 5.02
On June 30, 2026, Central Pacific Financial Corp.'s executive officers, including CEO Arnold D. Martines, entered into Change in Control Agreements establishing severance and equity-vesting arrangements triggered by involuntary termination without Cause or voluntary termination for Good Reason within specified periods around a change of control. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and is material as it establishes significant financial obligations and protections for named executives in a change-of-control scenario.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
Dr. Mung Chiang resigned from First Merchants Corporation's Board of Directors effective immediately on July 1, 2026, due to a change in professional responsibilities and relocation outside the company's primary market area. This is a clear director departure disclosed under Item 5.02, and board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
André Branch resigned as a director of Signet Jewelers Limited effective immediately on July 2, 2026. The disclosure explicitly states his departure was not due to disagreement with the Company, and the Board intends to reduce its size from 11 to 10 members in response. This is a clear director departure that would affect a reasonable investor's assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-02
Item 5.02
Shawn P. Payne was elected as a Director and appointed to serve as a member of the Project Risk Committee and chair of the Strategy Committee, effective July 1, 2026, in connection with his previously announced appointment as President and Chief Executive Officer. The principal disclosed action is a person taking on significant leadership roles, making this an executive appointment. This is material as it involves a CEO appointment and board election.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-02
Item 5.02
The filing discloses an Amended and Restated Supplemental Executive Retirement Agreement for James R. Barlow, the Chairman, President and CEO, effective July 1, 2026. The amendment increases the vesting percentage to 10% per year (accelerating vesting from the prior agreement), establishes a target retirement date of December 31, 2033 with annual retirement benefits of $120,000 over ten years, and includes change-of-control provisions. This is a material modification to executive compensation and retirement benefits arrangements, clearly falling under Item 5.02(e).
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-07-02
Item 8.01
Dollar Tree's Board approved a $2.5 billion share repurchase authorization on July 1, 2026. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." The authorization is material as it represents a significant commitment of capital and reflects the company's capital allocation strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-02
Item 8.01
Eos Energy announced commencement of a rights offering on July 2, 2026, pursuant to a shelf registration statement filed on Form S-3. The offering grants existing shareholders subscription rights to purchase units consisting of common stock and warrants at $5.481 per unit. This is a dilutive equity issuance that will increase the share count and warrant obligations, materially affecting existing shareholders' ownership percentages and the company's capital structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-02
The 6-K furnishes a notice to shareholders announcing payment of the second installment of a dividend decreed at the April 22, 2026 shareholders' meeting. The notice specifies the payment date (July 15, 2026), total amount (US$18,688,330.25), and per-share factor (US$0.019991920777278), with payment to be made in cash through the securities depository. This is a routine but material dividend distribution disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-02
Item 1.01
Alcoa entered into a definitive agreement to acquire South32's bauxite, alumina, and aluminum operations for $3.1 billion in cash plus approximately 17 million shares (valued at ~$1 billion) and up to $750 million in contingent payments, representing a significant expansion of Alcoa's production capacity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-02
Item 8.01
Alcoa entered into a Bridge Commitment Letter with Goldman Sachs Bank USA establishing a senior unsecured 364-day bridge term loan credit facility of up to $3.1 billion to finance the acquisition and related fees and expenses, with contemplated permanent financing through senior unsecured debt securities.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-02
Item 5.02
The filing discloses one-time retention awards (cash incentives and RSUs) approved by the Board on June 30, 2026 for three named executive officers: CEO Ameet Mallik ($1,795,500 cash + 675,000 RSUs), CFO Jose Carmona ($541,842 cash + 203,700 RSUs), and CMO Mohamed Zaki ($568,974 cash + 213,900 RSUs). This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and the aggregate amounts are material to investors assessing executive compensation and potential retention strategy.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-02
Item 7.01
The disclosure announces redemption notices for approximately 49,263 shares of Series A Redeemable Convertible Preferred Stock with a total redemption obligation of ~$52.1 million due December 28, 2026. This represents a material financial obligation that the company must address through strategic alternatives (debt/equity financing, asset sales, or lender consents). While the redemption right was previously disclosed, the actual exercise of that right and the company's liquidity constraints ($38.1M available vs. $52.1M obligation) constitute a material financial event affecting the company's capital structure and near-term financing needs.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
Priya Srinivasan, Chief People and Purpose Officer, notified the Company of her resignation effective August 31, 2026. This is a departure of a named executive officer. While the filing also mentions the appointment of Séverine Charbon as her successor, the principal disclosed action in Item 5.02 is Srinivasan's resignation, making exec_departure the most salient classification. The departure of a C-suite executive is material to investors assessing leadership continuity and organizational stability.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses the appointment of Nicholas Parker as Executive Vice President, Worldwide Field Operations, effective August 24, 2026, along with detailed compensation terms including a $1M base salary, $5M sign-on bonus, and $40M in equity grants. While the section also mentions Ajay K. Puri's retirement, the principal disclosed action centers on Parker's appointment to a senior executive role with material compensation arrangements. This is a significant leadership transition at a major technology company and would affect investor assessment of operational continuity and capital allocation.
View raw filing on EDGAR →